Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: A high proportion of people with intellectual disability have behaviour problems and psychotropic medication is a commonly used management strategy for these behaviours, despite lack of good-quality evidence to support this practice. RECENT FINDINGS: In recent years, one randomized controlled trial among adults and four on children with intellectual disability have been published showing effectiveness of low-dose risperidone in the management of behaviour problems as compared with placebo. Most of these randomized controlled trials are of good quality and included a reasonable number of participants. Most of these studies showed adverse effects, however, somnolence and weight gain particularly being associated with risperidone treatment. Most of the evidence on other psychotropic medications such as antidepressants, mood stabilizers, antianxiety drugs and opioid antagonists is difficult to interpret because it is based primarily on small case studies. SUMMARY: There is growing evidence in support of some antipsychotic medication, particularly the atypical antipsychotic, risperidone. Many of the studies of effectiveness included in this review have methodological flaws however. Therefore, the results need to be interpreted with caution. Furthermore, the paucity of evidence for some groups of medication does not necessarily mean that these medications are ineffective, but rather that their use is not currently supported by good-quality research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
Effects of Risperidone on Conduct and Disruptive Behavior Disorders in Children With Subaverage IQs
SNYDER, R., TURGAY, A., AMAN, M., BINDER, C., FISMAN, S., & CARROLL, A. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00002 · Cited by 335
Findling, R. L., Aman, M. G., Eerdekens, M., Derivan, A., Lyons, B., & The Risperidone Disruptive Behavior Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.677 · Cited by 161
Social skills training in adult psychiatric populations: A meta-analysis
Corrigan, P. W. (1991) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(91)90017-y · Cited by 126
Antipsychotic medication for challenging behaviour in people with learning disability
Brylewski, J., & Duggan, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000377.pub2 · Cited by 118
Cited by
Unwin, G. L., & Deb, S. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.07.031 · Cited by 62
Self-citationInterventions for challenging behaviour in intellectual disability
Ali, A., Blickwedel, J., & Hassiotis, A. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011577 · Cited by 51
Groves, L., Jones, C., Welham, A., Hamilton, A., Liew, A., & Richards, C. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00197-9 · Cited by 20
“We used the DerSimonian-Laird estimator, since QQ plots using this model indicated an approximately normal distribution of effects (appendix pp 9–11).”
BackgroundMethod
Metadata
- Authors
- Deb, S., & Unwin, G. L.
- Venue
- Current Opinion in Psychiatry
- Published
- 2007-09
- Volume
- 20
- Issue
- 5
- Pages
- 461-466
- ISSN
- 0951-7367 (ISSN-L)
- OpenAlex
- W2086772981
- Cited by
- 94
- References
- 6
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature. https://app.cochat.ai/papers/10.1097/yco.0b013e3282ab9952
- The paper
- Deb, S., & Unwin, G. L. (2007). Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e3282ab9952
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.